I have worked with university faculty and physicians for most of my career. But the professionals I find most consistently underserved by standard financial planning are not faculty and they are not physicians. They are the researchers — the principal investigators, lab directors, and senior scientists who built careers that do not fit neatly into the categories most financial planning conversations assume.
An academic faculty member has a relatively predictable income trajectory. A physician has a well-understood financial profile. A researcher’s income history looks like neither. It is shaped by grant cycles, institutional support, supplemental consulting income, indirect cost recovery structures, and in many cases, periods of reduced salary between funding awards. The planning opportunities embedded in that variability are real, and most researchers have never had anyone explain them.
The one I want to focus on here is charitable giving — specifically, the window that opens during the final active years of a research career, and why most researchers let it close without taking advantage of it.
How Grant Income Creates a Planning Window
A principal investigator whose laboratory receives a significant NIH or NSF award often sees a meaningful increase in their compensation in that year — through direct salary support, summer salary, or both. Senior scientists at research institutions may receive supplemental payments tied to specific programs or contracts. In some cases, deferred compensation from earlier in the career distributes during a terminal transition year.
Each of these creates a spike in taxable income. And every dollar of charitable contribution made in a high-income year reduces taxable income at the highest marginal rate the researcher will face in that period.
The challenge is that most researchers are making these giving decisions in December, after the income picture for the year is already clear, and after most of the planning opportunities have closed. A well-timed contribution to a donor-advised fund in an early high-income year can be significantly more valuable than the same contribution made later, at a lower marginal rate.
What a Donor-Advised Fund Actually Does
A donor-advised fund is a charitable giving account held at a sponsoring organization. The mechanics are straightforward: you contribute assets, receive an immediate tax deduction for the full amount, and then direct grants to qualified charitable organizations on your own schedule. The contribution year and the distribution year are separate decisions.
This structure is particularly well-suited to researchers for two reasons.
First, it allows the deduction to be taken in the high-income year without requiring the researcher to know at that moment exactly which institutions or causes will ultimately receive the funds. A researcher retiring from Yale who wants to support graduate student funding, a particular disease research area, or a community organization they have cared about for years can contribute now and make those determinations over the following months.
Second, DAFs can receive appreciated securities directly — not just cash. A researcher who holds appreciated stock, whether from consulting arrangements, institutional equity programs, or personal investments, can transfer those securities to a DAF without triggering capital gains tax on the appreciation. The deduction is for the full fair market value. The capital gain disappears.
The Appreciated Securities Opportunity
This is the part of the giving strategy that most researchers have never been walked through.
If a researcher holds $50,000 in appreciated stock with a cost basis of $20,000, selling the stock produces $30,000 in capital gains. At a 20 percent long-term capital gains rate, that is $6,000 in federal tax — before state taxes. The net amount available to donate is $44,000.
If the same researcher transfers the stock directly to a donor-advised fund, the capital gain disappears entirely. The deduction is for the full $50,000. The charity receives the full value. The researcher pays no capital gains tax. The difference is $6,000 in after-tax cost for the same charitable impact.
Over a career that has produced a meaningful investment portfolio, the cumulative difference between giving appreciated securities and giving cash is significant.
The Retirement Transition Window
For researchers within five years of retiring from an active laboratory role, the transition period deserves specific attention.
The final active years of a research career often represent the highest-income period: salary is at or near its peak, grants may be at full funding, and there may be consulting income or advisory fees that do not continue after the transition. This is the window when charitable contributions produce the largest tax benefit.
After retirement, income often drops meaningfully. Required minimum distributions from TIAA accounts and IRAs add back some taxable income, but the marginal rate applicable to those distributions is frequently lower than the rate that applied during the final working years. A deduction taken during the working years is worth more than the same deduction taken in retirement.
For researchers who have significant charitable intent and have not yet built a giving strategy around the transition window, the planning conversation is worth having before that window closes.
Qualified Charitable Distributions After Age 70½
Once a researcher reaches age 70½ and holds a traditional IRA or TIAA account subject to required minimum distributions, a different tool becomes available: the Qualified Charitable Distribution.
A QCD allows up to $105,000 annually (2024 figure, adjusted for inflation) to be transferred directly from a traditional IRA to a qualifying charity. The distribution satisfies the RMD requirement without appearing as taxable income. For researchers who do not need the full RMD to cover living expenses, this is one of the most tax-efficient giving strategies available.
One important constraint: QCDs cannot go to a donor-advised fund. They must be directed to a qualifying public charity. This means a DAF strategy and a QCD strategy serve complementary but distinct functions within a giving plan, and both may be appropriate at different points in the retirement transition.
A Starting Point
If you are a principal investigator, lab director, or senior research scientist and you have not yet built a giving strategy around your income picture, the place to start is straightforward.
Identify the years in your recent history or near-term future when income is meaningfully higher than average. Determine what appreciated assets you hold that could be contributed to a DAF without triggering capital gains. And consider whether a conversation about the transition window — before you leave the lab — is worth having.
The strategy is not complicated. The opportunity is time-limited.
If this is something you're interested in, I've written a full DAF guide here.
David Wheatley, CLU® ChFC®
Senior Partner, Financial Advisor
Tidewater Wealth Management | New Haven & West Hartford, CT